•  
  •  
 

Washington Journal of Law, Technology & Arts

Authors

Matthias Zigann

Abstract

Following recent regional court decisions on the infringement of second medical use patent claims, the German concept of manifest arrangement—previously believed to provide a safe harbor for generic pharmaceutical companies as long as they skinny-labeled their products—may be subject to a new interpretation. The German decisions are part of a Europe wide series of decisions on the same or similar subject matter and prove to be patent owner friendly.

First Page

245

Share

COinS